Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Prevention02:59

Cancer Prevention

7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Icariin as a Modulator of Cancer Cell Biology: Integrated Control of Proliferation, Cell Death Programs, Metastasis Signaling, and Delivery Challenges.

Cell biology international·2026
Same author

Molecular insights and antibiotic resistance genes characterization in clinical Vibrio cholera isolates from patients in Peshawar, Pakistan.

Molecular biology reports·2026
Same author

Synthesis and application of UV responsive detachable adhesives from epoxidized plant oils.

RSC advances·2026
Same author

Reply to Rhazzar et al. The Impact of Author Name Ambiguity on Bibliometric Validity. Comment on "Ejaz et al. Bibliometric Analysis of Publications on the Omicron Variant from 2020 to 2022 in the Scopus Database Using R and VOSviewer. <i>Int. J. Environ. Res. Public Health</i> 2022, <i>19</i>, 12407".

International journal of environmental research and public health·2026
Same author

Pomegranate in Cancer Therapy: A Review of Anticancer Potential, Mechanisms and Clinical Challenges in Breast, Colon and Prostate Cancers.

Phytotherapy research : PTR·2026
Same author

Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell-Cycle Control and Tumor Microenvironment Reprogramming.

Cell biology international·2026
Same journal

Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1-Dependent IRE1α-XBP1 Pathway.

Phytotherapy research : PTR·2026
Same journal

Lycium barbarum Leaf Flavonoids Exert Anti-Aging Effects by Regulating the Keap1-Nrf2-HO-1 and Cell Adhesion Molecule Signaling Pathways.

Phytotherapy research : PTR·2026
Same journal

Broussonin A Attenuates Type 2 Diabetic Osteoporosis by Reactivating JAK2/STAT3 Signaling to Inhibit Ferroptosis in BMSCs.

Phytotherapy research : PTR·2026
Same journal

Curcumin as a Multifaceted Epigenetic Modulator With a Disease-Oriented Perspective.

Phytotherapy research : PTR·2026
Same journal

A Critical Review of Cytochrome P450 Enzyme Inhibition by Herbal Phytochemicals: Implications for Drug Interaction Prediction and Herbal Safety.

Phytotherapy research : PTR·2026
Same journal

Curcumol Inhibits the Laminin-Facilitated Malignant Progression in Small-Cell Lung Cancer via Disrupting Laminin-Integrin β1 Interaction.

Phytotherapy research : PTR·2026
See all related articles

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.1K

Apigenin as an anticancer agent.

Muhammad Imran1, Tanweer Aslam Gondal2, Muhammad Atif3

  • 1University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore-Lahore, Lahore, Pakistan.

Phytotherapy Research : PTR
|February 15, 2020
PubMed
Summary
This summary is machine-generated.

Apigenin, a plant flavonoid, shows anticancer effects by inducing cell death and inhibiting invasion in various cancers. It modulates key signaling pathways like PI3K/Akt/NF-κB, offering potential therapeutic benefits.

Keywords:
apigeninbreast cancerflavonoidsglioblastomaliver cancerpancreatic cancerprostate cancer

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.6K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

607

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.1K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.6K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

607

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Apigenin is a plant-derived flavonoid with documented anticancer properties.
  • It affects multiple signaling pathways involved in cancer progression.

Purpose of the Study:

  • To investigate the molecular mechanisms of apigenin's anticancer effects.
  • To analyze its impact on apoptosis, invasion, and key signaling pathways in cancer cells.

Main Methods:

  • Apigenin treatment of human prostate cancer PC-3 cells.
  • Analysis of mRNA and protein expression for apoptosis markers (caspases, TNF-α, cytochrome c, Bax, Bcl-2).
  • Assessment of invasion-related proteins (MMPs, Snail, Slug) and signaling pathways (NF-κB, PI3K/Akt).

Main Results:

  • Apigenin induced apoptosis via extrinsic (caspase-3, -8, TNF-α) and intrinsic (cytochrome c, Bax) pathways.
  • It suppressed invasion by downregulating matrix metallopeptidases-2, -9, Snail, and Slug.
  • Apigenin reduced NF-κB, PI3K, Akt, and p-Akt levels, and decreased Oct3/4 expression.

Conclusions:

  • Apigenin exhibits potent anticancer activity by inducing apoptosis and inhibiting invasion.
  • Its effects are mediated through modulation of caspase-dependent and independent pathways.
  • Apigenin's downregulation of PI3K/Akt/NF-κB signaling and Oct3/4 suggests a role in suppressing cancer stemness.